Welcome to Oncologica
The New Prostatefocus Genetic Screening Test Identifies Men at Increased Risk of Developing Prostate Cancer
Our new Prostatefocus cancer genetic screening test identifies men at increased risk of developing prostate cancer. Prostate cancer is the most common cancer in men with 50,000 people in the UK diagnosed with the disease each year. 1 in 8 men in the UK will develop...
New Allergyfocus Test from Oncologica identifies over 99% of common allergies
Our new Allergyfocus test helps sufferers discover what common global allergens their bodies react to. Across the world allergies are on the rise. It is estimated that 20% of children and 30% of adults develop allergies in their lifetime. People can be allergic to...
Oncologica new research on detection of brain cancer biomarkers by genomic sequencing to improve survival rates
Glioblastoma, the most aggressive form of brain cancer is commonly treated with surgery, radiation, and chemotherapy. However, a newly published study from the research team at Oncologica the world-leading genetic cancer testing laboratory based in Cambridge UK,...
Our dedicated customer support team are ready to help you. Submit requests anytime via our Contact Us form - top right of screen, chat with the team via the tab bottom right or phone us on +44 (0) 1223 785327 9am - 5pm BST Mon - Fri.
Find what you need: